Literature DB >> 23255244

Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy.

Xufang Wang1, Huimei Chen, Mingchao Zhang, Zhihong Liu.   

Abstract

BACKGROUND: Inflammation contributes to renal injury of obesity-related glomerulopathy (ORG). As mast cells are regarded as regulators of inflammation, this study aimed to investigate whether mast cell infiltration is involved in renal damage of ORG.
METHODS: Forty patients with ORG, 18 with idiopathic focal segmental glomerulosclerosis and 10 normal controls were included in this study. Tryptase and CD68 were used for detecting mast cells and macrophages, respectively, by immunohistochemistry. Associations between mast cells and inflammation as well as clinicopathological parameters were assessed.
RESULTS: Tubulointerstitial mast cell infiltration increased in the ORG group compared with that in the focal segmental glomerulosclerosis and the control groups. The number of mast cells was positively correlated with body mass index (r = 0.432, P = 0.006), systolic blood pressure (r = 0.445, P = 0.005), serum creatinine (r = 0.489, P = 0.002), tubular atrophy (r = 0.470, P = 0.003) and interstitial fibrosis (r = 0.669, P < 0.001). Increased expression of monocyte chemoattractant protein-1, which was partly colocalized with tryptase, was observed. CD68-positive macrophages were also found to be increased and distributed around the mast cells. The area of tubulointerstitial monocyte chemoattractant protein-1 was correlated with the number of mast cells (r = 0.695, P < 0.001) and interstitial fibrosis (r = 0.327, P = 0.042). Multivariate regression showed that the number of mast cells was an independent predictor for epidermal growth factor receptor (R(2) = 0.313, P < 0.001).
CONCLUSIONS: Mast cell infiltration is involved in renal damage of ORG, and inflammation may contribute to such a process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23255244     DOI: 10.1097/MAJ.0b013e31827559f8

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Mast cell infiltration and obesity-related glomerulopathy: an under-recognized disease process and new ways to approach treatment.

Authors:  Mihran Naljayan; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

2.  Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy.

Authors:  Jiao He; Geheng Yuan; Fangxiao Cheng; Junqing Zhang; Xiaohui Guo
Journal:  Metab Syndr Relat Disord       Date:  2017-07-24       Impact factor: 1.894

3.  The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A.

Authors:  R Wagner; J Machann; M Guthoff; P P Nawroth; S Nadalin; M A Saleem; N Heyne; A Königsrainer; F Fend; F Schick; A Fritsche; N Stefan; H-U Häring; E Schleicher; D I Siegel-Axel
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 4.  Mast cell tissue heterogeneity and specificity of immune cell recruitment.

Authors:  Peter W West; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

5.  Reduction in Urinary Chemokine (C-C Motif) Ligand 2 (CCL2) After Surgery-Induced Weight Loss.

Authors:  Surita Binti Said; Guo Hou Loo; Nik Ritza Kosai; Reynu Rajan; Rozita Mohd; Asrul Abdul Wahab; Shamsul Azhar Shah
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.